FOR IMMEDIATE RELEASE 24 May 2024
Manx Financial Group PLC (the "Company")
Scrip Share Price
On 25 April 2024, the Company declared a dividend of 0.4551 pence per Ordinary Share ("Dividend") payable on 24 June 2024 to Holders of Ordinary Shares ("Shareholders") recorded on the register on 17 May 2024.
The Company has offered Shareholders the opportunity to receive the Dividend in new Ordinary Shares instead of cash and the final election date is 7 June 2024 at 5.00 p.m.
The share price for the Dividend has been determined as 19.00 pence per share. This has been calculated taking the lowest daily Volume Weighted Average Price ("VWAP") recorded by the Daily Official List of the London Stock Exchange plc during the period of twenty (20) dealing days prior to (and including) the ex-dividend date (capped at a 20% discount to the VWAP of the Ordinary Shares on the ex-dividend date).
The process for electing to participate in the scheme is detailed in the Scrip Dividend Circular which was posted to Shareholders on 8 May 2024 and is also available on the investor page of the Company's website www.mfg.im/investor-centre/aim-rule-26 (Circulars section).
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.
For further information, please contact:
| Manx Financial Group PLC Denham Eke, Executive Vice Chair Tel: +44 (0) 1624 694694
| Beaumont Cornish Limited Roland Cornish/James Biddle Tel: +44 (0) 20 7628 3396
| Greentarget Limited Jamie Brownlee Tel: +44 (0) 20 3307 5726
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
